ARTA
CNCE

A.R.T. Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

A.R.T. Advisors’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,341
Closed -$116K – 1274
2016
Q2 		$116K Sell
10,341
-29,104
-74% -$371K 0.01% 1189
2016
Q1 		$538K Sell
39,445
-29,200
-43% -$420K 0.02% 831
2015
Q4 		$1.3M Buy
68,645
+29,122
+74% +$633K 0.06% 453
2015
Q3 		$741K Buy
+39,523
New +$672K 0.03% 731
2014
Q4 		– Sell
-20,305
Closed -$256K – 1727
2014
Q3 		$256K Buy
+20,305
New +$197K 0.01% 1002

Other funds holding CNCE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

A.R.T. Advisors's CNCE Position: Q3 2016 in Review

A.R.T. Advisors sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2016, closing a stake of 10,341 shares — an estimated $116K sold.

A.R.T. Advisors first reported a position in CNCE in Q3 2014 and held it in 5 quarters. The position peaked at $1.3M in Q4 2015. 94 funds tracked by Wall St. Rank hold CNCE as of Q3 2016.

  • A.R.T. Advisors reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • A.R.T. Advisors sold 10,341 Concert Pharmaceuticals, Inc. shares in Q3 2016, an estimated $116K.
  • A.R.T. Advisors first reported a position in Concert Pharmaceuticals, Inc. in Q3 2014 and held it in 5 quarters.
  • A.R.T. Advisors's Concert Pharmaceuticals, Inc. position peaked at $1.3M in Q4 2015.
  • 94 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2016.

Based on A.R.T. Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.